Tetracyclic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S099000

Reexamination Certificate

active

07470683

ABSTRACT:
Compounds of formula I, of trans relative configuration:wherein:X represents an oxygen atom or an NR2group,Y represents a group selected from —CH2—, —(CH2)2— and —CH═CH—,R1and R2, which may be the same or different, each represents a hydrogen atom or a group selected from alkyl, cycloalkyl and cycloalkylalkyl,in racemic form or in the form of optical isomers,and also addition salts thereof with a pharmaceutically acceptable acid, and hydrates thereof.Medicinal products containing the same which are useful in the treatment of disorders of the central nervous system that involve the dopaminergic system.

REFERENCES:
patent: 0080115 (1983-06-01), None
patent: 0686637 (1995-12-01), None
patent: 0773223 (1997-05-01), None
patent: 0899267 (1999-03-01), None
Peglion, et al., “Tetracyclic analogs of [+]-S 14297: synthesis and determination of affinity and selectivity at cloned human dopamine D3 vs. D2 receptors” Bioorganic & Mecidinal Chemistry Letters, 7(7), 881-886, 1997.
French Preliminary Search Report for FR0608413 of Apr. 18, 2007.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tetracyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetracyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4047579

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.